Małgorzata Szczygieł

11PUBLICATIONS
31CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsGene and molecular therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 13, 2026
Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization.

Justyna Sopel, Katarzyna Sarad, Anna Kozinska

|Feb 09, 2026
RIPK4 function interferes with melanoma cell adhesion and metastasis.

Norbert Wronski, Sławomir Lasota, Ewelina Madej

|Jan 08, 2025
RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis.

Bartlomiej Olajossy, Norbert Wronski, Ewelina Madej

|Dec 17, 2024
Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX® Theranostic Nanoparticles.

Ewa Kowolik, Dariusz Szczygieł, Małgorzata Szczygieł

|Apr 27, 2024
Spin Trapping of Nitric Oxide by Hemoglobin and Ferrous Diethyldithiocarbamate in Model Tumors Differing in Vascularization.

Dariusz Szczygieł, Małgorzata Szczygieł, Anna Łaś

|Jan 31, 2024
EPR Monitoring of Oxygenation Levels in Tumors After Chlorophyllide-Based Photodynamic Therapy May Allow for Early Prediction of Treatment Outcome.

Małgorzata Szczygieł, Barbara Kalinowska, Dariusz Szczygieł

Pageof 2

Frequent Collaborators

7 joint publications

Martyna Elas

3 joint publications

Agnieszka Wolnicka-Glubisz

2 joint publications

Ewelina Madej

2 joint publications

Jarosław Czyż